📅 Published
March 20, 2026
(Friday)
March 20, 2026
(Friday)
Titan Biotech: 50x proof that quality compounds. Revenue ₹60 Cr → ₹300+ Cr. Debt-free. ROCE 20%+.
Stop chasing cheap stocks. Start owning quality.
Disclaimer: Educational only. Manish Goel, SEBI Reg. Advisor (INA100007736) | manishgoelstocks.com
📢 Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates — delivered straight to your phone!
✈️ Join @longtermequityy on Telegram
🔔 Free • No spam • Value investing insights daily
₹8 to ₹400 — 50x Returns! The Secret of Quality Investing #Shorts
